Iron oxide nanoparticles as magnetic resonance contrast agent for tumor imaging via folate receptor-targeted delivery1
- 1 September 2004
- journal article
- research article
- Published by Elsevier in Academic Radiology
- Vol. 11 (9) , 996-1004
- https://doi.org/10.1016/j.acra.2004.04.018
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Enhanced Tumor Detection Using a Folate Receptor-Targeted Near-Infrared Fluorochrome ConjugateBioconjugate Chemistry, 2003
- Folate-Targeted PEG as a Potential Carrier for Carboplatin Analogs. Synthesis and in Vitro StudiesBioconjugate Chemistry, 2003
- Assessment of global and regional myocardial function in the mouse using cine and tagged MRIMagnetic Resonance in Medicine, 2003
- Synthesis and Biological Evaluation of Folate Receptor-Targeted Boronated PAMAM Dendrimers as Potential Agents for Neutron Capture TherapyBioconjugate Chemistry, 2002
- Tumor Regression by Targeted Gene Delivery to the NeovasculatureScience, 2002
- Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptakeBiomaterials, 2002
- Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cellsNature Biotechnology, 2001
- Complete Mapping of Divergent Amino Acids Responsible for Differential Ligand Binding of Folate Receptors α and βPublished by Elsevier ,1999
- Design and Synthesis of [111In]DTPA−Folate for Use as a Tumor-Targeted RadiopharmaceuticalBioconjugate Chemistry, 1997
- Folate ReceptorsAnnual Review of Nutrition, 1996